-
Je něco špatně v tomto záznamu ?
Effect of a Low-Fat Vegan Diet on Body Weight, Insulin Sensitivity, Postprandial Metabolism, and Intramyocellular and Hepatocellular Lipid Levels in Overweight Adults: A Randomized Clinical Trial
H. Kahleova, KF. Petersen, GI. Shulman, J. Alwarith, E. Rembert, A. Tura, M. Hill, R. Holubkov, ND. Barnard
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, randomizované kontrolované studie, Research Support, N.I.H., Extramural
Grantová podpora
P30 DK045735
NIDDK NIH HHS - United States
R01 DK113984
NIDDK NIH HHS - United States
NLK
Directory of Open Access Journals
od 2018
ProQuest Central
od 2018-01-01
Health & Medicine (ProQuest)
od 2018-01-01
- MeSH
- absorpční fotometrie MeSH
- C-peptid metabolismus MeSH
- cholesterol metabolismus MeSH
- dieta s omezením tuků * MeSH
- dieta veganská * MeSH
- dospělí MeSH
- energetický metabolismus MeSH
- energetický příjem MeSH
- glykovaný hemoglobin metabolismus MeSH
- HDL-cholesterol metabolismus MeSH
- hepatocyty metabolismus MeSH
- inzulin metabolismus MeSH
- inzulinová rezistence MeSH
- játra diagnostické zobrazování metabolismus MeSH
- kosterní svalová vlákna metabolismus MeSH
- kosterní svaly diagnostické zobrazování metabolismus MeSH
- krevní glukóza metabolismus MeSH
- LDL-cholesterol metabolismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- metabolismus lipidů MeSH
- nadváha dietoterapie metabolismus MeSH
- nitrobřišní tuk diagnostické zobrazování MeSH
- obezita dietoterapie metabolismus MeSH
- postprandiální období MeSH
- protonová magnetická rezonanční spektroskopie MeSH
- senioři MeSH
- složení těla MeSH
- tělesná hmotnost MeSH
- triglyceridy metabolismus MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
- Research Support, N.I.H., Extramural MeSH
Importance: Excess body weight and insulin resistance lead to type 2 diabetes and other major health problems. There is an urgent need for dietary interventions to address these conditions. Objective: To measure the effects of a low-fat vegan diet on body weight, insulin resistance, postprandial metabolism, and intramyocellular and hepatocellular lipid levels in overweight adults. Design, Setting, and Participants: This 16-week randomized clinical trial was conducted between January 2017 and February 2019 in Washington, DC. Of 3115 people who responded to flyers in medical offices and newspaper and radio advertisements, 244 met the participation criteria (age 25 to 75 years; body mass index of 28 to 40) after having been screened by telephone. Interventions: Participants were randomized in a 1:1 ratio. The intervention group (n = 122) was asked to follow a low-fat vegan diet and the control group (n = 122) to make no diet changes for 16 weeks. Main Outcomes and Measures: At weeks 0 and 16, body weight was assessed using a calibrated scale. Body composition and visceral fat were measured by dual x-ray absorptiometry. Insulin resistance was assessed with the homeostasis model assessment index and the predicted insulin sensitivity index (PREDIM). Thermic effect of food was measured by indirect calorimetry over 3 hours after a standard liquid breakfast (720 kcal). In a subset of participants (n = 44), hepatocellular and intramyocellular lipids were quantified by proton magnetic resonance spectroscopy. Repeated measure analysis of variance was used for statistical analysis. Results: Among the 244 participants in the study, 211 (87%) were female, 117 (48%) were White, and the mean (SD) age was 54.4 (11.6) years. Over the 16 weeks, body weight decreased in the intervention group by 5.9 kg (95% CI, 5.0-6.7 kg; P < .001). Thermic effect of food increased in the intervention group by 14.1% (95% CI, 6.5-20.4; P < .001). The homeostasis model assessment index decreased (-1.3; 95% CI, -2.2 to -0.3; P < .001) and PREDIM increased (0.9; 95% CI, 0.5-1.2; P < .001) in the intervention group. Hepatocellular lipid levels decreased in the intervention group by 34.4%, from a mean (SD) of 3.2% (2.9%) to 2.4% (2.2%) (P = .002), and intramyocellular lipid levels decreased by 10.4%, from a mean (SD) of 1.6 (1.1) to 1.5 (1.0) (P = .03). None of these variables changed significantly in the control group over the 16 weeks. The change in PREDIM correlated negatively with the change in body weight (r = -0.43; P < .001). Changes in hepatocellular and intramyocellular lipid levels correlated with changes in insulin resistance (both r = 0.51; P = .01). Conclusions and Relevance: A low-fat plant-based dietary intervention reduces body weight by reducing energy intake and increasing postprandial metabolism. The changes are associated with reductions in hepatocellular and intramyocellular fat and increased insulin sensitivity. Trial Registration: ClinicalTrials.gov Identifier: NCT02939638.
Department of Cellular and Molecular Physiology Yale School of Medicine New Haven Connecticut
Department of Internal Medicine Yale School of Medicine New Haven Connecticut
George Washington University School of Medicine and Health Sciences Washington DC
Institute of Endocrinology Prague Czech Republic
Metabolic Unit CNR Institute of Neuroscience Padua Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011908
- 003
- CZ-PrNML
- 005
- 20210507103018.0
- 007
- ta
- 008
- 210420s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1001/jamanetworkopen.2020.25454 $2 doi
- 035 __
- $a (PubMed)33252690
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kahleova, Hana $u Physicians Committee for Responsible Medicine, Washington, DC
- 245 10
- $a Effect of a Low-Fat Vegan Diet on Body Weight, Insulin Sensitivity, Postprandial Metabolism, and Intramyocellular and Hepatocellular Lipid Levels in Overweight Adults: A Randomized Clinical Trial / $c H. Kahleova, KF. Petersen, GI. Shulman, J. Alwarith, E. Rembert, A. Tura, M. Hill, R. Holubkov, ND. Barnard
- 520 9_
- $a Importance: Excess body weight and insulin resistance lead to type 2 diabetes and other major health problems. There is an urgent need for dietary interventions to address these conditions. Objective: To measure the effects of a low-fat vegan diet on body weight, insulin resistance, postprandial metabolism, and intramyocellular and hepatocellular lipid levels in overweight adults. Design, Setting, and Participants: This 16-week randomized clinical trial was conducted between January 2017 and February 2019 in Washington, DC. Of 3115 people who responded to flyers in medical offices and newspaper and radio advertisements, 244 met the participation criteria (age 25 to 75 years; body mass index of 28 to 40) after having been screened by telephone. Interventions: Participants were randomized in a 1:1 ratio. The intervention group (n = 122) was asked to follow a low-fat vegan diet and the control group (n = 122) to make no diet changes for 16 weeks. Main Outcomes and Measures: At weeks 0 and 16, body weight was assessed using a calibrated scale. Body composition and visceral fat were measured by dual x-ray absorptiometry. Insulin resistance was assessed with the homeostasis model assessment index and the predicted insulin sensitivity index (PREDIM). Thermic effect of food was measured by indirect calorimetry over 3 hours after a standard liquid breakfast (720 kcal). In a subset of participants (n = 44), hepatocellular and intramyocellular lipids were quantified by proton magnetic resonance spectroscopy. Repeated measure analysis of variance was used for statistical analysis. Results: Among the 244 participants in the study, 211 (87%) were female, 117 (48%) were White, and the mean (SD) age was 54.4 (11.6) years. Over the 16 weeks, body weight decreased in the intervention group by 5.9 kg (95% CI, 5.0-6.7 kg; P < .001). Thermic effect of food increased in the intervention group by 14.1% (95% CI, 6.5-20.4; P < .001). The homeostasis model assessment index decreased (-1.3; 95% CI, -2.2 to -0.3; P < .001) and PREDIM increased (0.9; 95% CI, 0.5-1.2; P < .001) in the intervention group. Hepatocellular lipid levels decreased in the intervention group by 34.4%, from a mean (SD) of 3.2% (2.9%) to 2.4% (2.2%) (P = .002), and intramyocellular lipid levels decreased by 10.4%, from a mean (SD) of 1.6 (1.1) to 1.5 (1.0) (P = .03). None of these variables changed significantly in the control group over the 16 weeks. The change in PREDIM correlated negatively with the change in body weight (r = -0.43; P < .001). Changes in hepatocellular and intramyocellular lipid levels correlated with changes in insulin resistance (both r = 0.51; P = .01). Conclusions and Relevance: A low-fat plant-based dietary intervention reduces body weight by reducing energy intake and increasing postprandial metabolism. The changes are associated with reductions in hepatocellular and intramyocellular fat and increased insulin sensitivity. Trial Registration: ClinicalTrials.gov Identifier: NCT02939638.
- 650 _2
- $a absorpční fotometrie $7 D015502
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a krevní glukóza $x metabolismus $7 D001786
- 650 _2
- $a složení těla $7 D001823
- 650 _2
- $a tělesná hmotnost $7 D001835
- 650 _2
- $a C-peptid $x metabolismus $7 D002096
- 650 _2
- $a cholesterol $x metabolismus $7 D002784
- 650 _2
- $a HDL-cholesterol $x metabolismus $7 D008076
- 650 _2
- $a LDL-cholesterol $x metabolismus $7 D008078
- 650 12
- $a dieta s omezením tuků $7 D018752
- 650 12
- $a dieta veganská $7 D000067269
- 650 _2
- $a energetický příjem $7 D002149
- 650 _2
- $a energetický metabolismus $7 D004734
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a glykovaný hemoglobin $x metabolismus $7 D006442
- 650 _2
- $a hepatocyty $x metabolismus $7 D022781
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inzulin $x metabolismus $7 D007328
- 650 _2
- $a inzulinová rezistence $7 D007333
- 650 _2
- $a nitrobřišní tuk $x diagnostické zobrazování $7 D050152
- 650 _2
- $a metabolismus lipidů $7 D050356
- 650 _2
- $a játra $x diagnostické zobrazování $x metabolismus $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a kosterní svalová vlákna $x metabolismus $7 D018485
- 650 _2
- $a kosterní svaly $x diagnostické zobrazování $x metabolismus $7 D018482
- 650 _2
- $a obezita $x dietoterapie $x metabolismus $7 D009765
- 650 _2
- $a nadváha $x dietoterapie $x metabolismus $7 D050177
- 650 _2
- $a postprandiální období $7 D019518
- 650 _2
- $a protonová magnetická rezonanční spektroskopie $7 D066244
- 650 _2
- $a triglyceridy $x metabolismus $7 D014280
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 700 1_
- $a Petersen, Kitt Falk $u Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
- 700 1_
- $a Shulman, Gerald I $u Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut $u Department of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, Connecticut
- 700 1_
- $a Alwarith, Jihad $u Physicians Committee for Responsible Medicine, Washington, DC
- 700 1_
- $a Rembert, Emilie $u Physicians Committee for Responsible Medicine, Washington, DC
- 700 1_
- $a Tura, Andrea $u Metabolic Unit, CNR Institute of Neuroscience, Padua, Italy
- 700 1_
- $a Hill, Martin $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Holubkov, Richard $u School of Medicine, University of Utah, Salt Lake City
- 700 1_
- $a Barnard, Neal D $u Physicians Committee for Responsible Medicine, Washington, DC $u George Washington University School of Medicine and Health Sciences, Washington, DC
- 773 0_
- $w MED00205674 $t JAMA network open $x 2574-3805 $g Roč. 3, č. 11 (2020), s. e2025454
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33252690 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507103017 $b ABA008
- 999 __
- $a ok $b bmc $g 1650311 $s 1132287
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 3 $c 11 $d e2025454 $e 20201102 $i 2574-3805 $m JAMA network open $n JAMA Netw Open $x MED00205674
- GRA __
- $a P30 DK045735 $p NIDDK NIH HHS $2 United States
- GRA __
- $a R01 DK113984 $p NIDDK NIH HHS $2 United States
- LZP __
- $a Pubmed-20210420